Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02437279
Brief Title: Study to Identify the Optimal Adjuvant Combination Scheme of Ipilimumab and Nivolumab in Melanoma Patients (OpACIN)

First Submitted : April 13, 2015
First Submitted that Met QC Criteria : May 4, 2015
First Posted : May 7, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : October 15, 2020
Last Update Posted : October 19, 2020